Wnt ligand expression in malignant melanoma: pilot study indicating correlation with histopathological features.
about
Therapy for BRAFi-Resistant Melanomas: Is WNT5A the Answer?CTLA-4 is a direct target of Wnt/beta-catenin signaling and is expressed in human melanoma tumors.Prognostic parameters for the primary care of melanoma patients: what is really risky in melanoma?The role of Wnt signaling in cancer and stem cells.Targeting the Wnt signaling pathway to treat Barrett's esophagus.Melanocyte receptors: clinical implications and therapeutic relevance.Phenylmethimazole decreases Toll-like receptor 3 and noncanonical Wnt5a expression in pancreatic cancer and melanoma together with tumor cell growth and migration.Developmental pathways activated in melanocytes and melanoma.WLS inhibits melanoma cell proliferation through the β-catenin signalling pathway and induces spontaneous metastasis.Targeting c-Met in melanoma: mechanism of resistance and efficacy of novel combinatorial inhibitor therapy.Upregulation of frizzled 9 in astrocytomas.Inhibition of Wnt-2-mediated signaling induces programmed cell death in non-small-cell lung cancer cells.1-Benzyl-indole-3-carbinol is a highly potent new small molecule inhibitor of Wnt/β-catenin signaling in melanoma cells that coordinately inhibits cell proliferation and disrupts expression of microphthalmia-associated transcription factor isoform-MFrizzled-10 and cancer progression: Is it a new prognostic marker?Wnt5a and PKC, a deadly partnership involved in melanoma invasion.
P2860
Q26782222-C265DDBF-A623-49C3-9767-6672EEC662C4Q35101747-E8454B71-ADA2-474C-A748-B8FE4302BF4EQ35324807-7E6A0600-EC9D-4D57-BD04-17ED270BB86BQ36429628-D5D6DEB4-A75E-4FB4-BD6B-416ECFF13779Q36734947-24114FE5-6935-4E44-9A1E-25CBF9B50E2BQ36954814-C90A9D30-6F36-44E2-94A5-C0D552D27332Q37394701-4DACD3A6-BF38-40F4-9EEB-DFCCFEDE1B39Q38238576-6BF7A442-D79E-4556-AAF9-8775419CE12FQ38456692-2F6063CF-611D-46CA-BA6D-3F4438487C52Q38986202-B7575691-734D-460B-B8FE-A40DE9891BA4Q40212341-FFE0EF2F-2D65-4497-BA15-D7172EA8F341Q40543122-3324010A-3936-4EC3-A6BB-9FF534651DC0Q46030038-0110E416-2206-4110-9535-494C15F9A0E4Q49343572-92198267-A1C1-4E3F-825D-40770101129AQ52681447-5F03E6B9-9A99-4387-97A1-0DEF2220B102
P2860
Wnt ligand expression in malignant melanoma: pilot study indicating correlation with histopathological features.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Wnt ligand expression in malig ...... th histopathological features.
@en
type
label
Wnt ligand expression in malig ...... th histopathological features.
@en
prefLabel
Wnt ligand expression in malig ...... th histopathological features.
@en
P2093
P2860
P356
P1476
Wnt ligand expression in malig ...... th histopathological features.
@en
P2093
P2860
P304
P356
10.1136/MP.56.5.280
P407
P577
2003-10-01T00:00:00Z